Australian Clinical Labs Ltd
ASX:ACL
Income Statement
Earnings Waterfall
Australian Clinical Labs Ltd
Income Statement
Australian Clinical Labs Ltd
| Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||
| Interest Expense |
15
|
15
|
12
|
12
|
13
|
15
|
17
|
16
|
15
|
|
| Revenue |
647
N/A
|
867
+34%
|
996
+15%
|
818
-18%
|
697
-15%
|
674
-3%
|
696
+3%
|
728
+5%
|
741
+2%
|
|
| Gross Profit | ||||||||||
| Cost of Revenue |
(120)
|
(158)
|
(208)
|
(177)
|
(126)
|
(116)
|
(119)
|
(127)
|
(128)
|
|
| Gross Profit |
527
N/A
|
709
+34%
|
788
+11%
|
641
-19%
|
571
-11%
|
558
-2%
|
577
+3%
|
601
+4%
|
613
+2%
|
|
| Operating Income | ||||||||||
| Operating Expenses |
(399)
|
(449)
|
(516)
|
(519)
|
(509)
|
(514)
|
(519)
|
(534)
|
(545)
|
|
| Selling, General & Administrative |
(271)
|
(314)
|
(341)
|
(340)
|
(328)
|
(329)
|
(328)
|
(336)
|
(342)
|
|
| Depreciation & Amortization |
(88)
|
(94)
|
(106)
|
(119)
|
(123)
|
(126)
|
(128)
|
(133)
|
(136)
|
|
| Other Operating Expenses |
(40)
|
(41)
|
(69)
|
(60)
|
(59)
|
(59)
|
(63)
|
(65)
|
(67)
|
|
| Operating Income |
128
N/A
|
260
+103%
|
272
+5%
|
122
-55%
|
62
-49%
|
44
-29%
|
58
+32%
|
67
+17%
|
68
+1%
|
|
| Pre-Tax Income | ||||||||||
| Interest Income Expense |
(15)
|
(15)
|
(12)
|
(12)
|
(13)
|
(15)
|
(17)
|
(15)
|
(14)
|
|
| Non-Reccuring Items |
(19)
|
(49)
|
(6)
|
(8)
|
0
|
(5)
|
(5)
|
(4)
|
(2)
|
|
| Total Other Income |
(7)
|
(6)
|
0
|
0
|
(0)
|
0
|
0
|
(2)
|
(4)
|
|
| Pre-Tax Income |
87
N/A
|
190
+120%
|
255
+34%
|
103
-60%
|
48
-53%
|
23
-52%
|
36
+55%
|
46
+27%
|
48
+4%
|
|
| Net Income | ||||||||||
| Tax Provision |
(26)
|
(57)
|
(76)
|
(29)
|
(12)
|
(8)
|
(12)
|
(15)
|
(15)
|
|
| Income from Continuing Operations |
60
|
134
|
178
|
74
|
36
|
16
|
24
|
31
|
33
|
|
| Income to Minority Interest |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Net Income (Common) |
60
N/A
|
134
+121%
|
178
+34%
|
73
-59%
|
36
-51%
|
15
-57%
|
24
+55%
|
31
+28%
|
32
+6%
|
|
| EPS (Diluted) |
0.3
N/A
|
0.67
+123%
|
0.88
+31%
|
0.37
-58%
|
0.18
-51%
|
0.07
-61%
|
0.12
+71%
|
0.15
+25%
|
0.17
+13%
|
|